Lista de obras -

9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium

artículo científico publicado en 2012

Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis

artículo científico publicado en 2017

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

artículo científico publicado en 2015

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies

artículo científico publicado en 2010

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study

artículo científico publicado en 2010

Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: A prospective long-term follow-up study ⬇️

artículo científico publicado el 19 de noviembre de 2011

Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients.

artículo científico publicado en 2017

Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial

artículo científico publicado en 2012

Breast fine-needle aspiration cytology performance in the high-risk screening population: a study of BRCA1/BRCA2 mutation carriers

artículo científico publicado en 2013

Choices for women at risk of hereditary breast cancer

artículo científico publicado en 2013

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.

artículo científico publicado en 2011

Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer

artículo científico publicado en 2011

Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis

artículo científico publicado en 2016

Correction: MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging

artículo científico publicado en 2013

Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined

artículo científico publicado en 2012

Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients

artículo científico publicado en 2007

Exploring the course of psychological distress around two successive control visits in women at hereditary risk of breast cancer

Exploring the link between MORF4L1 and risk of breast cancer

artículo científico publicado en 2011

Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer

artículo científico publicado en 2006

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers

artículo científico publicado en 2013

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2010

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

artículo científico publicado en 2014

Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization

artículo científico publicado en 2015

Hereditary breast cancer growth rates and its impact on screening policy

artículo científico publicado en 2005

Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients

artículo científico publicado en 2015

Long‐term psychological distress in women at risk for hereditary breast cancer adhering to regular surveillance: a risk profile ⬇️

artículo científico publicado el 7 de febrero de 2012

Lower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomy

scientific article published on 14 January 2014

Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysis

artículo científico publicado en 2014

Mammographic screening in BRCA1 mutation carriers postponed until age 40: Evaluation of benefits, costs and radiation risks using models

artículo científico publicado en 2016

MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer.

artículo científico publicado en 2018

Optimal age to start preventive measures in women withBRCA1/2mutations or high familial breast cancer risk

artículo científico publicado en 2013

Optimized nLC-MS workflow for laser capture microdissected breast cancer tissue ⬇️

artículo científico publicado el 24 de enero de 2012

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

artículo científico publicado en 2016

Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression

artículo científico publicado en 2015

Preoperative Breast MRI Can Reduce the Rate of Tumor-Positive Resection Margins and Reoperations in Patients Undergoing Breast-Conserving Surgery ⬇️

artículo científico publicado el 1 de febrero de 2013

Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic

artículo científico publicado en 2007

Proteomic characterization of microdissected breast tissue environment provides a protein-level overview of malignant transformation

artículo científico publicado en 2017

Psychological distress in women at increased risk for breast cancer: the role of risk perception

article by Silvia van Dooren et al published September 2004 in European Journal of Cancer

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

artículo científico publicado en 2014

Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study

artículo científico publicado en 2014

Sensitivity to first-line chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2009

Should we screen BRCA1 mutation carriers only with MRI? A multicenter study

artículo científico publicado en 2014

Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy

artículo científico publicado en 2009

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).

artículo científico publicado en 2015

The impact of social and personal resources on psychological distress in women at risk for hereditary breast cancer

artículo científico publicado en 2010

Eficacia de la resonancia magnética y la mamografía para el cribado del cáncer de mama en mujeres con predisposición familiar o genética.

artículo científico publicado en 2004

Lista de obras de

9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium

Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study

Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: A prospective long-term follow-up study ⬇️

Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients.

Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial

Breast fine-needle aspiration cytology performance in the high-risk screening population: a study of BRCA1/BRCA2 mutation carriers

Choices for women at risk of hereditary breast cancer

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.

Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer

Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis

Correction: MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging

Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined

Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients

Exploring the course of psychological distress around two successive control visits in women at hereditary risk of breast cancer

Exploring the link between MORF4L1 and risk of breast cancer

Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization

Hereditary breast cancer growth rates and its impact on screening policy

Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients

Long‐term psychological distress in women at risk for hereditary breast cancer adhering to regular surveillance: a risk profile ⬇️

Lower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomy

Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysis

Mammographic screening in BRCA1 mutation carriers postponed until age 40: Evaluation of benefits, costs and radiation risks using models

MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer.

Optimal age to start preventive measures in women withBRCA1/2mutations or high familial breast cancer risk

Optimized nLC-MS workflow for laser capture microdissected breast cancer tissue ⬇️

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression

Preoperative Breast MRI Can Reduce the Rate of Tumor-Positive Resection Margins and Reoperations in Patients Undergoing Breast-Conserving Surgery ⬇️

Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic

Proteomic characterization of microdissected breast tissue environment provides a protein-level overview of malignant transformation

Psychological distress in women at increased risk for breast cancer: the role of risk perception

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study

Sensitivity to first-line chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers

Should we screen BRCA1 mutation carriers only with MRI? A multicenter study

Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).

The impact of social and personal resources on psychological distress in women at risk for hereditary breast cancer

Eficacia de la resonancia magnética y la mamografía para el cribado del cáncer de mama en mujeres con predisposición familiar o genética.